CPIM
JAZZ icon

Columbia Partners Investment Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Columbia Partners Investment Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-13,800
Closed -$2.26M – 342
2014
Q4 		$2.26M Buy
+13,800
New +$2.29M 0.12% 194
2014
Q2 		– Sell
-5,895
Closed -$817K – 357
2014
Q1 		$817K Sell
5,895
-1,822
-24% -$274K 0.04% 304
2013
Q4 		$976K Buy
+7,717
New +$799K 0.04% 266

Other funds holding JAZZ

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
WBC
Westpac Banking Corp Sydney, Australia $1.44B AUM 28.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Columbia Partners Investment Management's JAZZ Position: Q1 2015 in Review

Columbia Partners Investment Management sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2015, closing a stake of 13,800 shares — an estimated $2.26M sold.

Columbia Partners Investment Management first reported a position in JAZZ in Q4 2013 and held it in 3 quarters. The position peaked at $2.26M in Q4 2014. 355 funds tracked by Wall St. Rank hold JAZZ as of Q1 2015.

  • Columbia Partners Investment Management reported no remaining Jazz Pharmaceuticals position as of Q1 2015 after selling out during the quarter.
  • Columbia Partners Investment Management sold 13,800 Jazz Pharmaceuticals shares in Q1 2015, an estimated $2.26M.
  • Columbia Partners Investment Management first reported a position in Jazz Pharmaceuticals in Q4 2013 and held it in 3 quarters.
  • Columbia Partners Investment Management's Jazz Pharmaceuticals position peaked at $2.26M in Q4 2014.
  • 355 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2015.

Based on Columbia Partners Investment Management's 13F filing for Q1 2015, filed 13 May 2015.